Results 31 to 40 of about 1,230 (95)
БОЛЕЗНЬ КРОНА: ФАРМАКОЭКОНОМИЧЕСКИЕ АСПЕКТЫ ВЕДЕНИЯ ПАЦИЕНТОВ
University Therapeutic Journal, 2021 Юрий Павлович Успенский +2 more
doaj
Качественная клиническая практика, 2018 Aim. To assess the pharmacoeconomic feasibility of including lenvatinib in the list of vital and essential drugs (VED) and the state program for providing to the necessary drugs to treat patients with differentiated radioiodine-resistant thyroid cancer ...
S. K. Zyryanov, I. N. Dyakov
doaj +1 more source
ФАРМАКОЭКОНОМИКА КАК НОВЫЙ ИНСТРУМЕНТ ФАРМАЦЕВТИЧЕСКОГО МАРКЕТИНГА
, 2015 A properly conducted pharmacoeconomic study and its results are a new element in the body of evidence for drugs recently introduced into clinical practice.
M. V. Protsenko +3 more
core
Клинико-экономический анализ оригинального левофлоксацина при туберкулезе
Качественная клиническая практика, 2018 Актуальность. Российская Федерация включена в число 22 стран, несущих наибольшее бремя заболевания туберкулёзом, поскольку при относительно невысоком показателе заболеваемости (77,4 чел. на 100 тыс. населения) абсолютное число больных велико и по оценкам
doaj
Basal insulin analogues in the diabetes mellitus type 2 control — economic aspects
Качественная клиническая практика, 2018 Economic aspects of insulin analogues — glargine and detemir — in the control of diabetes mellitus type 2 (DM 2) has been prepared in according to needs of the Russian health care system.
D. Yu. Belousov, E. V. Afanasyeva
doaj
Pharmacoeconomic analysis of perampanel for resistance partial epilepsy
Качественная клиническая практика, 2018 Partial epilepsy is the most common type of seizures. Th e prevalence of partial epilepsy in Russia reached 325 thousand patients, with resistant to therapy about 276 thousand. Objective.
D. Yu. Belousov +2 more
doaj
Качественная клиническая практика, 2018 Aim. To perform health-economic evaluation of trastuzumab emtansine (T-DM1) in patients with HER2+ breast cancer and CNS metastases. Materials and methods.
A. S. Kolbin +4 more
doaj
Фармакоэкономика хронической болезни почек
, 2018 A pharmacoeconomic study is a comprehensive scientific and research activity, which should take into account specific characteristics of a research subject as well as nosology based on common methodological approaches of pharmacoeconomics,.
V. G. Serpik +9 more
core
Качественная клиническая практика, 2018 Проведен анализ "затраты-эффективность" актовегина, кавинтона и трентала у больных с дисциркуляторными ...
doaj
Pharmacoeconomic analysis of anti-VEGF therapy for age-related macular degeneration
Качественная клиническая практика, 2018 Diabetes mellitus (DM) is a widespread, severe disease that has outpaced many infectious and non-infectious diseases in terms of both incidence increases and economic burden in most developed countries.
A. E. Cheberda +2 more
doaj +1 more source